PEDIATRICS Vol. 46 No. 4 October 1970, pp. 648
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ng, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ng, L. M.

Possible Hazards of Handling Antineoplastic Drugs

Lawrence M. Ng M.B.1

1 Children's Hospital Medical Center, 51st and Grove Streets Oakland, California 94609

The introduction of the newer experimental antileukemic and antineoplastic drugs like L-asparaginase, 5-fluorouracil, dibromodulcitol, pseudourea, and so forth, and the published data of the group studies give light to the outlook of childhood cancers. However, most of these new drugs in addition to the older ones (including daunomycin, actinomycin D, vincristine, cytosine arabinoside, and so forth) have to be prepared fresh and given by intravenous or intramuscular injections. As a hematology resident, I have to give four to six such injections daily.